Extended Prophylaxis of Venous Thromboembolism with Idraparinux
- 13 September 2007
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 357 (11) , 1105-1112
- https://doi.org/10.1056/nejmoa067703
Abstract
The extended use of vitamin K antagonists for prophylaxis against venous thromboembolism is often constrained by risk–benefit limitations and inconvenience. We evaluated the efficacy and safety of a 6-month extension of prophylaxis against recurrent venous thromboembolism with idraparinux in patients who had initially received 6 months of prophylaxis with an anticoagulant.Keywords
This publication has 13 references indexed in Scilit:
- Idraparinux versus Standard Therapy for Venous Thromboembolic DiseaseNew England Journal of Medicine, 2007
- Eight-Year Follow-Up of Patients With Permanent Vena Cava Filters in the Prevention of Pulmonary EmbolismCirculation, 2005
- Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous ThrombosisAnnals of Internal Medicine, 2004
- A novel long‐acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A Phase II evaluationJournal of Thrombosis and Haemostasis, 2004
- Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor XimelagatranNew England Journal of Medicine, 2003
- Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary EmbolismNew England Journal of Medicine, 2003
- Extended Oral Anticoagulant Therapy after a First Episode of Pulmonary EmbolismAnnals of Internal Medicine, 2003
- Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous ThromboembolismNew England Journal of Medicine, 2003
- Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous ThrombosisNew England Journal of Medicine, 2001
- A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous ThromboembolismNew England Journal of Medicine, 1995